FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

14976011000001107: Targinact 20mg/10mg modified-release tablets (Napp Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
52775501000001118 Targinact 20mg/10mg modified-release tablets (Napp Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
52775601000001119 Targinact 20mg/10mg modified-release tablets (Napp Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Targinact 20mg/10mg modified-release tablets (Napp Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Targinact 20mg/10mg modified-release tablets (Napp Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
Targinact 20mg/10mg modified-release tablets (Napp Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Targinact 20mg/10mg modified-release tablets (Napp Pharmaceuticals Ltd) Is a Oxycodone 20mg / Naloxone 10mg modified-release tablets true Inferred relationship Existential restriction modifier
Targinact 20mg/10mg modified-release tablets (Napp Pharmaceuticals Ltd) Has active ingredient Naloxone hydrochloride false Inferred relationship Existential restriction modifier
Targinact 20mg/10mg modified-release tablets (Napp Pharmaceuticals Ltd) Has active ingredient Oxycodone hydrochloride false Inferred relationship Existential restriction modifier
Targinact 20mg/10mg modified-release tablets (Napp Pharmaceuticals Ltd) Has manufactured dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
Targinact 20mg/10mg modified-release tablets (Napp Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Targinact 20mg/10mg modified-release tablets (Napp Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Targinact 20mg/10mg modified-release tablets (Napp Pharmaceuticals Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Targinact 20mg/10mg modified-release tablets (Napp Pharmaceuticals Ltd) Has excipient Stearyl alcohol false Inferred relationship Existential restriction modifier
Targinact 20mg/10mg modified-release tablets (Napp Pharmaceuticals Ltd) Is a Targinact true Inferred relationship Existential restriction modifier
Targinact 20mg/10mg modified-release tablets (Napp Pharmaceuticals Ltd) Has specific active ingredient Oxycodone hydrochloride true Inferred relationship Existential restriction modifier
Targinact 20mg/10mg modified-release tablets (Napp Pharmaceuticals Ltd) Has specific active ingredient Naloxone hydrochloride true Inferred relationship Existential restriction modifier
Targinact 20mg/10mg modified-release tablets (Napp Pharmaceuticals Ltd) Has active ingredient Oxycodone true Inferred relationship Existential restriction modifier
Targinact 20mg/10mg modified-release tablets (Napp Pharmaceuticals Ltd) Has active ingredient Naloxone true Inferred relationship Existential restriction modifier
Targinact 20mg/10mg modified-release tablets (Napp Pharmaceuticals Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Targinact 20mg/10mg modified-release tablets (Napp Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Targinact 20mg/10mg modified-release tablets (Napp Pharmaceuticals Ltd) Has manufactured dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Targinact 20mg/10mg modified-release tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Is pack of False Targinact 20mg/10mg modified-release tablets (Napp Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier
Targinact 20mg/10mg modified-release tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has AMP True Targinact 20mg/10mg modified-release tablets (Napp Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start